P&G Health stock surges 18% after strong Q4 results with 56% profit growth and margin expansion, driven by brand strength, supply chain efficiency, and steady demand outlook.
Tieten Medicity Hospital has successfully performed one of Thane’s first robotic telesurgeries for gall bladder removal (robotic cholecystectomy) using the indigenously developed Mizzo Endo 4000 robotic surgical system.
.jpeg "Bengaluru Ebola Scare Ends Negative, Triggers Health Alert")
Bengaluru Ebola scare ends negative, but triggers health alert as authorities ramp up airport screening, surveillance, and isolation protocols amid global outbreak concerns.
Tata Elxsi has launched ViTel, an AI-driven material intelligence solution for medical device manufacturers, co-developed with Viridium AI. The new platform, formally introduced today at DeviceTalks Boston 2026, aims to help MedTech companie...
Sun Pharma reported a strong financial performance for the fourth quarter of FY26, with Sun Pharma Q4 revenue rising 13.6 per cent to Rs. 14,560 crore and Sun Pharma net profit jumping 26.2 per cent to Rs. 2,714 crore, reflecting healthy growt...
India’s heatwave crisis is turning into a public health emergency, with rising heatstroke deaths, underreported mortality, and growing strain on healthcare systems.
New clinical review validates capsaicin 0.075% for diabetic neuropathy pain relief, offering targeted, localized therapy with improved patient comfort and safety.
Regeneron’s Hyderabad GCC highlights India’s growing role in global biopharma R&D. The move signals a shift beyond cost arbitrage toward high-value capabilities in AI, clinical trials, and data-driven drug development.
.jpeg "Patent Exclusivity Expiry Recalibrating India's Pharma Logistics")
Patent exclusivity expiry of $200–300B drugs is reshaping India’s pharma logistics. Rising generics, biosimilars, and cold-chain demand are driving investments in air cargo, ports, and compliant supply chains.
.jpeg "Moderna & Merck Combo Cuts Melanoma Spread Risk by 59% in 5-Year Study")
Moderna and Merck melanoma combo cuts spread risk by 59% in 5-year study. Personalized cancer vaccine with Keytruda shows strong survival gains and recurrence prevention.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")